Clinical Trials Browser

Phase 1 × Lymphoma, B-Cell × Injections × Clear all

NCT06565689 2026-02-05

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

Phase 1 Recruiting

Recurrence, Lymphoma, B-Cell

NCT05618327 2025-12-02

Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Phase 1 Active not recruiting

Lymphoma, B-Cell